It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Commentary: Triptan use during pregnancy: a safe choice?
https://arctichealth.org/en/permalink/ahliterature99383
Source
Headache. 2010 Apr;50(4):576-8
Publication Type
Article
Date
Apr-2010
More detail
Author
Tobias Kurth
Sonia Hernandez-Diaz
Author Affiliation
From the Institut national de santé et de recherche médicale (INSERM), Unit 708 - Neuroepidemiology, Paris, France.
Source
Headache. 2010 Apr;50(4):576-8
Date
Apr-2010
Language
English
Geographic Location
Norway
Publication Type
Article
Keywords
Abnormalities, Drug-Induced - epidemiology
Bias (epidemiology)
Causality
Cerebrovascular Disorders - chemically induced - epidemiology
Comorbidity
Data Interpretation, Statistical
Drug Toxicity - epidemiology
Female
Humans
Migraine Disorders - drug therapy
Norway - epidemiology
Pregnancy
Pregnancy Complications - chemically induced - epidemiology
Pregnancy Trimester, First - drug effects
Prenatal Exposure Delayed Effects - chemically induced - epidemiology
Registries
Reproducibility of Results
Risk assessment
Risk factors
Tryptamines - adverse effects
Notes
RefSource: Headache. 2010 Apr;50(4):563-75
PubMed ID
20456148
View in PubMed
Less detail
Permalink